Scientists plan huge painkiller risk study
$100m trial comes in the wake of Vioxx, Bextra withdrawals
The Cleveland Clinic Foundation said yesterday that it will direct a massive, $100 million clinical trial to assess risks that three popular painkillers may pose to people with heart problems. (Full article: 756 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
